Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.34 USD | -0.01% | +1.89% | -4.29% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.32M 5.91M |
---|---|---|---|---|---|
Net income 2024 * | -14M -19.14M | Net income 2025 * | -18M -24.6M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.65
x | P/E ratio 2025 * |
-1.3
x | Employees | 6 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.17% |
Latest transcript on Artelo Biosciences, Inc.
1 day | -0.01% | ||
1 week | +1.89% | ||
Current month | -9.47% | ||
1 month | -6.95% | ||
3 months | -8.23% | ||
6 months | -5.55% | ||
Current year | -4.29% |
Managers | Title | Age | Since |
---|---|---|---|
Gregory Gorgas
CEO | Chief Executive Officer | 61 | 17-04-02 |
Andy Yates
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Steven D. Reich
CTO | Chief Tech/Sci/R&D Officer | - | 18-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Connie Matsui
CHM | Chairman | 70 | 17-05-01 |
Steven Kelly
BRD | Director/Board Member | 59 | 17-05-01 |
Gregory Reyes
BRD | Director/Board Member | 70 | 20-11-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.34 | -0.01% | 5,726 |
24-04-25 | 1.34 | -0.13% | 5,281 |
24-04-24 | 1.342 | +2.43% | 5,411 |
24-04-23 | 1.31 | +0.74% | 15,876 |
24-04-22 | 1.3 | -1.11% | 3,574 |
Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.29% | 4.32M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ARTL Stock